# OnCo record paper-her2climb-nejm-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-her2climb-nejm-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-her2climb-nejm-2020" ;
  schema:name "HER2CLIMB: tucatinib with trastuzumab and capecitabine for HER2-positive metastatic breast cancer, including brain metastases"@en ;
  schema:description "Adding the brain-penetrant HER2 pill tucatinib to trastuzumab and capecitabine lengthened survival in heavily pretreated HER2-positive metastatic breast cancer, and uniquely the trial included patients with active brain metastases, who also benefited."@en ;
  schema:url <https://onco.cc/key-papers/paper-her2climb-nejm-2020/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1914609>, <https://pubmed.ncbi.nlm.nih.gov/31825569/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1914609> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Murthy RK, Loi S, Okines A, et al." ;
  onco:cancers <https://onco.cc/cancers/her2-positive-breast-brain-metastases/> ;
  onco:drugs <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/tucatinib/> ;
  onco:trials <https://onco.cc/trials/her2climb/> ;
  onco:journals <https://onco.cc/journals/nejm/> .